These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3086490)

  • 1. Heterogeneities of two components of C2 toxin produced by Clostridium botulinum types C and D.
    Ohishi I; Okada Y
    J Gen Microbiol; 1986 Jan; 132(1):125-31. PubMed ID: 3086490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and characterization of heterologous component IIs of botulinum C2 toxin.
    Ohishi I; Hama Y
    Microbiol Immunol; 1992; 36(3):221-9. PubMed ID: 1376392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular permeability activity of botulinum C2 toxin elicited by cooperation of two dissimilar protein components.
    Ohishi I; Iwasaki M; Sakaguchi G
    Infect Immun; 1981 Mar; 31(3):890-5. PubMed ID: 7014465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of C2 toxin by Clostridium botulinum types C and D as determined by its vascular permeability activity.
    Ohishi I; Sakaguchi G
    Infect Immun; 1982 Jan; 35(1):1-4. PubMed ID: 7033132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homogeneity and heterogeneity of toxins produced by Clostridium botulinum type C and D strains.
    Oguma K; Syuto B; Agui T; Iida H; Kubo S
    Infect Immun; 1981 Nov; 34(2):382-8. PubMed ID: 6171518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of antigenicity of toxins produced by Clostridium botulinum type C and D strains.
    Ochanda JO; Syuto B; Oguma K; Iida H; Kubo S
    Appl Environ Microbiol; 1984 Jun; 47(6):1319-22. PubMed ID: 6204594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of two components of botulinum C2 toxin.
    Ohishi I; Iwasaki M; Sakaguchi G
    Infect Immun; 1980 Dec; 30(3):668-73. PubMed ID: 6785232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of toxins of Clostridium butyricum and Clostridium botulinum type E.
    Giménez JA; Sugiyama H
    Infect Immun; 1988 Apr; 56(4):926-9. PubMed ID: 3126148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interconversion of type C and D strains of Clostridium botulinum by specific bacteriophages.
    Eklund MW; Poysky FT
    Appl Microbiol; 1974 Jan; 27(1):251-8. PubMed ID: 4589131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relation between toxicity and toxin-related-antigen contents of Clostridium botulinum types C and D cultures as determined by mouse bioassay and ELISA.
    Notermans S; Dufrenne J; Kozaki S
    Jpn J Med Sci Biol; 1982; 35(5-6):203-11. PubMed ID: 6761472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Clostridium botulinum type E toxin purified by two different procedures.
    Yokosawa N; Tsuzuki K; Syuto B; Oguma K
    J Gen Microbiol; 1986 Jul; 132(7):1981-8. PubMed ID: 2432159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NAD-glycohydrolase activity of botulinum C2 toxin: a possible role of component I in the mode of action of the toxin.
    Ohishi I
    J Biochem; 1986 Aug; 100(2):407-13. PubMed ID: 3023308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of botulinum C2 toxin by trypsin.
    Ohishi I
    Infect Immun; 1987 Jun; 55(6):1461-5. PubMed ID: 3570475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic similarity of toxins produced by Clostridium botulinum type C and D strains.
    Oguma K; Syuto B; Iida H; Kubo S
    Infect Immun; 1980 Dec; 30(3):656-60. PubMed ID: 6785231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a monoclonal antibody-based immunoassay for detecting type B Clostridium botulinum toxin produced in pure culture and an inoculated model cured meat system.
    Gibson AM; Modi NK; Roberts TA; Hambleton P; Melling J
    J Appl Bacteriol; 1988 Apr; 64(4):285-91. PubMed ID: 3049499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that botulinum C2 toxin has two dissimilar components.
    Iwasaki M; Ohishi I; Sakaguchi G
    Infect Immun; 1980 Aug; 29(2):390-4. PubMed ID: 7011974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noncorrelation between mouse toxicity and serologically assayed toxin in Clostridium botulinum type A culture fluids.
    Betley MJ; Sugiyama H
    Appl Environ Microbiol; 1979 Aug; 38(2):297-300. PubMed ID: 391153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomics of Clostridium botulinum group III strains.
    Sakaguchi Y; Suzuki T; Yamamoto Y; Nishikawa A; Oguma K
    Res Microbiol; 2015 May; 166(4):318-25. PubMed ID: 25111022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium botulinum subtype Ba.
    Giménez DF
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):68-72. PubMed ID: 6380157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of the outer membrane and toxin localization of Clostridium botulinum type E [proceedings].
    Ohyama A; Yabuuchi E; Ito T; Tanimura E; Yamamoto N
    Jpn J Med Sci Biol; 1978 Apr; 31(2):170-2. PubMed ID: 355685
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.